Psychedelic Science 2023

Be Part of

        the Breakthrough

Presented by

Trauma and psychedelic-assisted therapy


Trauma and psychedelic-assisted therapy

Dr. Barbara Rothbaum has been researching and delivering evidence-based treatment (EBT) for PTSD since 1986. In this talk, she will enumerate the advantages of combining MDMA with prolonged exposure therapy (PE) for PTSD. PE is a well-studied, effective, well disseminated EBT with many PE trainers worldwide. PE is recommended as a first-line treatment in every published treatment guideline for PTSD. There is theoretical support for a synergistic mechanism of action for adding MDMA to PE. Translational research supports that MDMA facilitates the extinction of fear in a rodent model. In a healthy human model, more extinction recall responders were in the MDMA condition.

Share: Trauma and psychedelic-assisted therapy


Already Registered?

If you already registered for the in-person portion of the Psychedelic Science 2023 conference, get immediate access to PS2023: The Virtual Trip by logging in with the email address you used when signing up for the conference. We’ll email you a login link—no password necessary!

Need to Register?

If you are not yet registered for Psychedelic Science 2023, you can sign up for PS2023: The Virtual Trip access by creating an account.